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Paper spray ionization mass spectrometry as a potential tool for early 
diagnosis of cervical cancer
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ABSTRACT: Squamous intraepithelial lesion is an abnormal growth of epithelial cells on the surface of the cervix that may lead to 
cervical cancer. Analytical protocols for the determination of squamous intraepithelial lesions are highly demanded since cervical 
cancer is the fourth most diagnosed cancer among women in the world. Here, paper spray ionization mass spectrometry (PSI-MS) is 
used  to  distinguish  between  healthy  (negative  for  intraepithelial  lesion  or  malignancy)  and  diseased  (high-grade  squamous 
intraepithelial lesion) blood plasmas. A total of 86 blood samples of different women (healthy = 49 samples; diseased = 37 samples) 
were collected, and the plasmas were prepared. Then, 10 µL of each plasma sample was deposited onto triangular papers for PSI-MS 
analysis. No additional step of sample preparation was necessary. The interval-successive projection algorithm linear discriminant 
analysis (iSPA-LDA) was applied to the PSI mass spectra, showing six ions (mostly phospholipids) that were predictive of healthy 
and diseased plasmas. Values of 77% of accuracy, 86% of sensitivity, 80% of PPV, and 75% of NPV were achieved. This study 
provides evidence that PSI-MS may potentially be used as a fast and simple analytical technique for early diagnosis of cervical cancer.
Keywords:  Mass Spectrometry, Ambient Mass Spectrometry, Paper Spray ionization, cervical cancer
Cervical  cancer  is  the  fourth  most  diagnosed  cancer  among 
women in the world.1 The incidence of this cancer is higher in low- 
and middle-income countries than in high-income countries, and 
one  of  the  main  reasons  for  this  is  the  low  quality  of  cancer 
screening.2 For example, in Brazil, a study3 demonstrated that low 
quality of cervical cancer screening (lack of access, late 
examination,  and  lack  of  guidance)  was  lower  according  to  the 
increase in human development index (HDI) and per capita 
household income, while indigenous women had the highest 
prevalence of outcomes. Therefore, adequate screening and early 
diagnosis  are  essential  aspects  involved  in  the  progress  against 
cervical cancer.
Historically, the Papanicolaou test, more technically referred to 
as  cytology,  has  been  the  most  used  method  for  cervical  cancer 
screening. This method is based on discerning normal and 
malignant cervical cells by viewing swabs smeared on microscopic 
slides.4 However, growing evidence suggests that cytology alone 
may not be reliable since this method is subjective, and its 
sensitivity  is  quite  variable  (approximately  30-87%),5,6  with  less 
sensitivity (up to 11%) in developing countries. 4,7 An alternative 
and  more  sensitive  method  for  cervical  cancer  screening  is  the 
human papillomavirus (HPV) test, which tests for the presence of 
the HPV, rather than the tissue changes of cervical cancer. 8 HPV 
infection causes squamous intraepithelial lesions, which are 
abnormal growths of epithelial cells on the surface of the cervix 
that may lead to cervical cancer. 9 These precancerous lesions are 
classified as low- or high-grade squamous intraepithelial lesions, 
according  to  their  potentiality  to  become  cervical  cancer  over 
time.10 The HPV test has been widely used since the discovery that 
the virus is associated with upward of 95% of cervical 
malignancies.8 However, due to the high sensitivity, the HPV test 
is  often  associated  with  false-positive  outcomes  due  to  the  high 
prevalence of the virus and hence tends to decrease the specificity 
of screening.11,12 Therefore, new methodologies that may 
complement or even improve current protocols are highly required.
Mass spectrometry-based methods such as gas chromatography 
coupled  to  mass  spectrometry  (GC-MS),  liquid  chromatography 
coupled to mass spectrometry (LC-MS), and matrix-assisted laser 
desorption/ionization (MALDI-MS) are techniques widely used in 
cancer research due to their ability to determine chemical profiles 
of tissues or biological fluids (for example, urine or blood 
serum/plasma) and find biomarkers associated with different types 
of cancer,13-15 including cervical cancer.16-21 Although GC-MS and 
LC-MS provide reliable results with excellent analytical 
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performance, both techniques require extensive and arduous 
sample preparation steps before instrumental analysis, consuming 
reagents or solvents, and generating chemical waste. On the other 
hand, MALDI-MS requires the use of a matrix prior to MS analysis, 
which  makes  it  a  time-consuming  approach  due  to  the  sample 
preparation steps for mixing and co-crystalizing the sample with 
the  matrix,  in  addition  to  making  difficult  the  analysis  of  small 
molecules  due  to  the  interference  of  matrix  ions  in  the  low  m/z 
region  of  the  mass  spectrum.  Therefore,  analytical  methods  that 
require  minimal  sample  preparation,  consume  less  quantity  of 
solvent  or  sample,  and  provide  adequate  chemical  profiles  for 
cancer diagnosis are highly desirable.
Ambient mass spectrometry (AMS) techniques have been 
developed to fulfill the aforementioned requirements, allowing the 
analysis of compounds directly from their native environment with 
minimal or no sample preparation.22 Desorption electrospray 
ionization (DESI)23 and direct analysis in real-time (DART)24 were 
the first AMS techniques developed, followed by a large number of 
AMS methods that have been used for direct analysis of a wide 
range of analytes and samples. 25,26 Among the AMS techniques, 
paper spray ionization (PSI) is one of the most simple, inexpensive, 
and capable of providing results in a short-time analysis. In PSI-
MS, a triangular paper is used as a substrate to generate analyte ions 
for MS. The sample is deposited onto the triangular paper, which is 
subsequently  moistened  with  a  solvent.  When  a  high  voltage  is 
applied to the paper, a spray with charged droplets is generated at 
the paper tip and goes towards the mass spectrometer inlet for MS 
analysis.27 The analytical performance of PSI-MS has been 
evaluated  in  a  wide  range  of  applications  including  detection  of 
drugs in fingerprint samples,28 quantifications of pesticides in fruits 
and vegetables,29,30 characterization of energetic polymers,31 
investigations  of  inks  and  questioned  documents,32  analysis  of 
drugs of abuse,33,34 and coupling to portable mass spectrometers for 
on-site analysis.35 In addition, PSI-MS has been widely employed 
in clinical diagnosis36-43 due to its ability to allow biofluid analysis 
using a small amount of sample with minimal or even no sample 
preparation (for example, by applying few microliters of plasma, 
serum, or whole blood directly onto a triangular paper), which can 
significantly  reduce  the  invasiveness  to  the  patients  and  waiting 
time  for  clinical  reports.  Consequently,  PSI-MS  emerges  as  a 
potential tool for early diagnosis of cervical cancer.
In this study, we propose, for the first time, the use of PSI-MS 
as  a  fast  and  straightforward  method  for  discriminating  between 
healthy  (negative  for  intraepithelial  lesion  or  malignancy)  and 
diseased (high-grade squamous intraepithelial lesion) blood plasma 
samples. A total of 86 blood samples of different women (healthy 
= 49 samples; diseased = 37 samples) were collected and submitted 
to  plasma  preparation,  followed  by  the  deposition  of  the  plasma 
samples onto triangular papers for MS analysis. No additional step 
of  sample  preparation  was  necessary.  In  addition,  because  MS 
provides  such  a  wealth  of  chemical  information,  this  technique 
invites  a  statistical  analysis.  Thus,  we  combined  the  chemical 
information  provided  by  the  PSI-MS  analysis  with  the  interval-
successive projection algorithm linear discriminant analysis (iSPA-
LDA) to classify blood plasma as healthy or diseased and also to 
select those molecular features most indicative of the disease state.
EXPERIMENTAL SECTION 
Collection  and  preparation  of  specimens. Women 
from  the  Rio  Grande  do  Norte  (Brazil),  attending  the  Januario 
Cicco  Maternity  School  of  the  public  health  system  for  cervical 
pathology screening consultations and reference services for 
colposcopy, were volunteers from July 2014 to March 2016. All 
volunteers were between 18 and 62 years old (mean age of 37 and 
34 for healthy and diseased women, respectively), including 
whites,  blacks,  and  multiracials.  In  addition,  these  women  were 
under varied social/healthy conditions, such as first sexual 
intercourse, marriage, use of contraceptive methods, and 
consumption  of  alcohol  and  cigarette.  The  Institutional  Ethics 
Committee for Human Research of the Onofre Lopes University 
Hospital at the Federal University of Rio Grande do Norte (Brazil) 
approved this study (protocol #526/11). Written informed consent 
was  obtained  from  all  subjects.  A  total  of  86  blood  samples  of 
different women were collected by venipuncture into tubes 
containing the anticoagulant ethylenediaminetetraacetic acid 
(EDTA). Within two hours after blood collection, the plasma was 
separated  by  density  gradient,  and  aliquots  were  transferred  into 
cryogenic tubes and stored at −80°C until analysis. Shortly after 
blood  collection,  women  were  submitted  to  cytology  smears  or 
large-loop  excision  of  the  transformation  zone  (LLETZ).  For 
samples obtained from LLETZ, the histopathological analysis was 
performed on sections from paraffin blocks in 4 μm thickness and 
stained with hematoxylin/eosin. The histopathological analysis was 
performed to avoid misleading results from the cytology test, since 
the  latter  is  well  known  for  its  low  sensitivity.  Cytology  and 
histopathology were reported according to the Bethesda System:44 
49  patients  diagnosed  as  negative  for  intraepithelial  lesion  or 
malignancy and 37 patients diagnosed with high-grade squamous 
intraepithelial lesions.
Paper spray ionization mass spectrometry. The  PSI 
parameters were used according to protocols previously 
demonstrated by our group.29,30,37,45,46 The paper (Whatman #1, 11 
μm pores, purchased from Whatman International Ltd., Maidstone, 
UK) was cut into an equilateral triangle shape (1 cm sides) and held 
by  a  metal  clip  connected  to  the  voltage  source  of  the  mass 
spectrometer. The paper tip was positioned approximately 4 mm 
from  the  mass  spectrometer  inlet.  A  volume  of  10  µL  of  blood 
plasma was applied onto the paper. Lower volumes (2, 5, and 7 µL) 
were tested but did not provide satisfactory analyte signals. After 
the  deposition  of  the  sample  onto  the  triangular  paper,  different 
drying times were evaluated under open-air conditions and at room 
temperature (23º): 0 (shortly after plasma application), 5, 30, and 
60 min. Methanol (MeOH), MeOH/H 2O (50:50), and acetonitrile 
(ACN)/H2O (50:50), all with 0.1% formic acid, were tested as the 
spray solvent at a volume of 15 µL. The analyses were performed 
in triplicate. Mass spectra were recorded for 1 min/sample 47 using 
a Thermo Scientific LCQ Fleet ion trap mass spectrometer (San 
Jose, USA). The positive ionization mode was used throughout the 
experiment because it provided abundant peaks of lipids, 
compounds  widely  studied  in  cancer  diagnostic  research.48  The 
negative ionization mode did not provide detection of lipids and, 
therefore, it was not used in the experiments. Other instrumental 
parameters were optimized by varying one variable and fixing all 
the others, and the best conditions were as follows: scan range: m/z 
100-1000; spray voltage: 3.5 kV; capillary temperature: 275 °C; 
capillary voltage: 10 V; tube lens: 50 V; activated AGC; maximum 
injection  time:  100  ms;  microscans:  2.  The  mass  spectra  were 
processed using the Xcalibur Analysis software package (Version 
2.0, Service Release 2, Thermo Electron Corporation). Each mass 
spectrum was summed at the total ion current (1 min of 
acquisition), converted to txt file, and used for statistical analysis.
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Identification of ions. Predictive compounds were 
identified  by  collision-induced  dissociation  (CID)  experiments 
using  the  LCQ  Fleet  ion  trap  mass  spectrometer.  The  isolation 
window was 1 m/z, and the collision energy ranged from 15 to 30 
(manufacturer’s  unit).  Fragmentation  patterns  were  compared  to 
literature reports and compared to data from Lipidmaps 
(www.lipidmaps.org). Lipids were characterized by fatty acid 
composition, but the stereochemistry of the chains and double bond 
position is unknown. In addition, to improve identification of the 
predictive  ions,  the  plasma  samples  were  analyzed  by  PSI-MS 
(same protocol described in the subsection “paper spray ionization 
mass spectrometer”) using a high-resolution Q Exactive™ hybrid 
Quadrupole-Orbitrap  mass  spectrometer  (Thermo  Scientific,  San 
Jose, USA). Six samples (3 healthy and 3 diseased) were analyzed 
using Q Exactive, and the chemical profiles were compared to those 
obtained using the LCQ mass spectrometer. No statistical method 
was applied to the high-resolution mass spectra. The optimized Q 
Exactive parameters were as follows: positive ion mode; m/z 500-
1000; resolution: 140,000; spray voltage: 3.5 kV; capillary 
temperature: 275°C; S-lens RF Level: 50%; activated AGC; 
maximum injection time: 100 ms; microscans: 2.
Statistical analysis. Initially, the spectral data were baseline 
corrected  using  the  Xcalibur  software.  In  MATLAB  (version 
R2014b environment, MathWorks Inc., Natick, USA), the spectra 
were mass drift corrected by a lab-made routine to ensure that all 
mass spectra were the same size and that all peaks were aligned. 
The alignment of peaks was carried out using an in-house 
developed algorithm. The alignment was performed with the raw 
spectra, and  the resolution  was  set at  0.1  m/z.  Subsequently,  the 
spectra  were  pre-processed  by  normalization  so  that  the  sum  of 
squares of each row (spectrum) was equal to 1 and mean-centered. 
Before modeling, samples were divided into training (~70%, n = 
60 samples: healthy = 35, diseased = 25) and test sets (~30%, n = 
26 samples: healthy = 14, diseased = 12) using the Kennard-Stone 
sample selection algorithm. The training data were used for model 
construction  and  optimization,  and  the  test  data  for  final  model 
evaluation. The percentage ratio of the ion intensities in the mass 
spectra  was  employed  in  the  construction  of  the  model.  Each 
spectrum  had  a  final  size  of  7,040  m/z  values.  The  iSPA-LDA 
method was applied to 7 window intervals, where intervals 1 to 6 
were 1006 m/z values in size, while interval 7 was 1004 m/z values 
in size. In iSPA-LDA, a successive projection algorithm is applied 
to the training set in order to reduce the pre-processed data interval 
to a few numbers of orthogonal variables (i.e., m/z values). This is 
performed by minimizing the average risk of misclassification G,49 
calculated for each m/z window interval in the validation set as:
                                                                                (1)� = 1�∑�� = 1��
where N is the number of training samples, and  is defined as: ��
                                                   (2)�� = �2(��,��(�))min�(�) ≠ �(�) �2(��,��(�))
where  is the squared Mahalanobis distance between �2(��,��(�))
the sample  and the mean  of its true class, and  �� ��(�) �2(��,��(�))
is the squared Mahalanobis distance between the sample  and the ��
mean  of the closest wrong class. Finally, a linear ��(�)
discriminant analysis classifier is applied to a matrix that contains 
the selected variables concatenated from each interval. The 
performance  of  the  model  was  evaluated  by  means  of  accuracy 
(total number of samples that are correctly classified considering 
true and false negatives), sensitivity (proportion of positive tests 
that  are  correctly  identified),  specificity  (proportion  of  negative 
tests that are correctly identified), positive predictive value (PPV, 
number  of  positive  tests  that  are  true  positives),  and  negative 
predictive  value  (NPV,  number  of  negative  tests  that  are  true 
negatives).50 These parameters are calculated as follows: 
                               (3) Accuracy(%) = ( TP + TNTP + FP + TN + FN) × 100
                                         (4) Sensitivity(%) = ( TPTP + FN) × 100
                                         (5) Specificity(%) = ( TNTN + FP) × 100
                                                    (6) PPV(%) = ( TPTP + FP) × 100
                                                   (7)NPV(%) = ( TNTN + FN) × 100
where TP is defined as true positives, TN as true negatives, FP as 
false positives, and FN as false negatives.
RESULTS AND DISCUSSION 
Initial  experiments  were  carried  out  to  investigate  the  most 
appropriate spray solvent. Methanol (MeOH), MeOH/H2O (50:50), 
and acetonitrile (ACN)/H2O (50:50) were tested, and the results are 
shown in Figure S-1. The analysis was performed by applying 15 
µL  of  the  solvent  shortly  after  the  application  of  10  µL  of  the 
plasma sample (healthy). A similar profile was achieved between 
MeOH and MeOH/H2O, and ACN/H2O showed a lower 
normalized level (NL), with abundant contaminant signals at m/z 
522  and  m/z  550.  Thus,  MeOH  was  selected  for  the  subsequent 
analyses, although MeOH/H2O (50:50) could be successfully 
employed.  Other  combinations  of  solvent  systems  can  also  be 
tested, and this will certainly be considered in future works.
Subsequent experiments were performed to determine how long 
the blood plasma needs to be dried after its application onto the 
triangular paper. Figure 1 shows the mass spectra obtained by the 
PSI-MS analysis of 10 µL of a plasma sample (diseased) using the 
following drying times: 0 (shortly after sample application), 5, 30, 
and 60 min. The best condition was assessed based on the NL value 
from the sum of 1 min of acquisition. All the analyses provided 
mass spectra with satisfactory quality, showing high-intensity ions 
at the m/z 700-850 region, which are typical of lipids. No different 
ionic species were detected using the different drying times, but 
small differences in ion intensities were verified, as demonstrated 
by the NL values in Figure 1. In addition, by checking the extracted 
ion  chromatogram  of  each  abundant  ion  from  0  to  60  min,  the 
differences in intensities were less than 10%. Since avoiding drying 
of the sample increases the speed of the PSI-MS analysis, which is 
highly desirable in clinical diagnosis, the subsequent analyses were 
performed shortly after the sample application onto the triangular 
paper. 
Posteriorly, PSI-MS was used to analyze 86 samples of blood 
plasma in order to discriminate between 49 healthy and 37 diseased 
samples.  Ions  at  the  m/z  700-900  region  were  detected  in  both 
healthy (Figure 2a) and diseased (Figure 2b) plasmas, but different 
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relative abundances were verified. For example, the relative 
abundances of m/z 808 and 834 were higher in healthy samples, 
whereas the abundances of m/z 725, 782, and 796 were higher in 
diseased plasmas. The ion at m/z 579 was detected only in diseased 
samples. These results suggest that these ions may be responsible 
for the differentiation between healthy and diseased plasmas since 
the difference in relative abundances of ions as a factor to 
discriminate between normal and cancer samples are very common 
in ambient MS reports.51-54
Figure 1. Evaluation of different drying times of a blood plasma sample 
(diseased) after application of 10 µL of sample onto the triangular paper for 
PSI(+)-MS analysis: (a) 0 (shortly after sample application); (b) 5 min; (c) 
30 min; (d) 60 min. NL = normalized level. Each mass spectrum is a sum 
of 1 min of acquisition.
 
Figure 2. Representative mass spectra obtained by the PSI(+)-MS analysis 
of (a) healthy and (b) diseased plasmas.
After analyzing all blood plasmas, the iSPA-LDA algorithm was 
used to evaluate the discrimination between healthy and diseased 
plasmas and also to identify the molecular features responsible for 
the discrimination. According to the chemometric model, the six 
ions  mentioned  in  the  previous  paragraph  were  predictive  of 
healthy and diseased plasmas. Detailed information about them is 
demonstrated  in  Table  1.  Tentative  assignments  were  performed 
using high-resolution MS, and molecular formulas of sodiated and 
potassiated  lipids  were  achieved  with  mass  errors  below  1  ppm. 
The data were compared to data from Lipidmaps 
(www.lipidmaps.org). Interestingly, the chemical profiles of 
healthy  and  diseased  samples  obtained  by  high-resolution  MS 
(Figure S-2) were similar to those obtained by low-resolution MS, 
which provides evidence that the same compounds were detected 
using both instruments, avoiding misleading assignments. MS/MS 
experiments (Figure S-3) were also performed in order to improve 
identification. Even though the isomerism of the double bonds in 
the fatty acid chains of complex lipids complicates precise 
structural  assignment,  the  MS/MS  experiments  were  useful  in 
identifying categories of lipids through the fragmentation patterns 
that are common to them. For example, losses of trimethylamine (-
59 Da) and phosphocholine (-183 Da) were helpful in identifying 
the sphingomyelin (SM) and phosphatidylcholine (PC) lipids 55-58 
(see details in Figure S-3). In particular, a concern arises with the 
lipid LPI(P-16:0), which has not been previously detected in blood 
plasma samples (as far as we know). The LPI(P-16:0), also known 
as PI(P-16:0/0:0), is a phosphatidylinositol, a class of lipids 
popularly known by the acronyms PI followed by the structures of 
the side chains within parentheses. Several PI lipids (e.g., PI (32:1), 
PI (34:1), PI (34:2), PI (36:2), PI (36:4), and some others) have 
already been detected in blood plasma by MS.59 The identification 
of  LPI(P-16:0)  reported  here  is  not  accurate  and  will  require 
specific identification experiments in future work. Note, however, 
that not knowing precisely the identity of chemical markers is not 
an obstacle to using an analytical technique as a potential tool for 
discrimination between healthy and diseased samples.  
Table 1. Values of m/z and mass errors obtained by high-resolution MS, 
along with proposed molecular formulas, tentative annotations, and relative 
abundances (low-resolution MS data) of the molecular features responsible 
for discrimination between healthy and diseased plasmas




579.29041 -0.103 [C25H49O11P + Na]+ LPI(P-16:0)
Diseased (30%) 
Healthy (0%)
725.55661 -0.256 [C39H79N2O6P + Na]+ SM(34:1)
Diseased (28%) 
Healthy (10%)
782.56681 -0.276 [C42H82NO8P + Na]+ PC(34:1)
Diseased (67%) 
Healthy (53%)
796.52501 -0.381 [C42H80NO8P + K]+ PC(34:2)
Diseased (35%) 
Healthy (27%)
808.58232 -0.440 [C44H84NO8P + Na]+ PC(36:2)
Diseased (38%) 
Healthy (45%)
834.59798 -0.415 [C46H86NO8P + Na]+ PC(38:3)
Diseased (16%) 
Healthy (24%)
aError  in  ppm; brelative  abundances  of  predictive  ions  for  healthy  and 
diseased samples.
The  iSPA-LDA  algorithm  was  used  in  this  work  because  the 
mass  spectra  data  are  ill-conditioned  due  to  the  high  degree  of 
collinearity between the variables and the large number of variables 
(7,004 variables) in comparison with the small number of samples. 
This makes impossible the application of LDA directly to spectral 
data.  The  use  of  iSPA  as  a  variable  selection  technique  prior  to 
LDA  reduces  ill-condition  problems  since  the  selected  variables 
have no collinearity. After variable selection, the number of sample 
spectra will be larger than the number of input variables for LDA, 
which makes the calculation feasible.
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Figure 3 illustrates the predictions of the plasma samples studied 
by  the  iSPA-LDA  model.  The  y-axis  represents  the  calculated 
response  to  identify  diseased  plasmas.  A  horizontal  line  was 
determined  from  training  samples  for  maximum  discrimination 
between diseased and healthy plasmas. Samples located above the 
horizontal line are identified as belonging to the diseased group. 
The results of the statistical parameters for classification of the 
plasma samples according to the iSPA-LDA model are shown in 
Table  2.  A  value  of  77%  of  accuracy  was  achieved,  which  is  a 
satisfactory value considering the clinical diagnosis since an 
overall classification error below 25% was found. The model also 
showed 86% sensitivity and 67% specificity. In addition, the PPV 
and NPV values were 80% and 75%, respectively, indicating that 
the blood plasmas with high-grade squamous intraepithelial lesions 
(diseased samples) are better classified than healthy plasmas, which 
suggests that this model may have the potential to be used in early 
diagnosis of cervical cancer. The confusion matrix for the test set 
is  shown  in  Table  S-1.  By  using  principal  component  analysis 
(PCA),  no  apparent  segregation  between  healthy  controls  and 
diseased samples was observed (Figure S-4). Other classification 
algorithms,  such  as  soft  independent  modelling  of  class  analogy 
(SIMCA) and genetic algorithm linear discriminant analysis (GA-
LDA)  were  also  tested,  but  the  iSPA-LDA  outperformed  them: 
GA-LDA (test accuracy = 73%), SIMCA (test accuracy = 58%).
The variables selected by iSPA-LDA are the m/z values with the 
greatest  discriminant  power.  Hence,  these  variables  are  directly 
associated with cervical cancer diagnosis. The use of PSI-MS with 
this  chemometric  approach  provides  both  the  classification  of 
samples in an objective fashion and the objective identification of 
the  m/z  values  responsible  for  class  differentiation,  therefore, 
providing important information about cervical cancer 
biochemistry.
Figure 3. Calculated response of the iSPA-LDA model for the 
identification of diseased plasma samples. The horizontal line represents a 
limit for sample discrimination. Samples located above the horizontal line 
are identified as belonging to the diseased group.
Table  2.  Results  of  the  statistical  parameters  for  classification  of  blood 





Positive predictive value (PPV) 80
Negative predictive value (NPV) 75
The results above are consistent with previous studies that used 
PSI-MS for discrimination between healthy and cancerous 
samples. For example, Wang et al. 60 used PSI-MS for analysis of 
human prostate tumor tissue and healthy tissue. The authors 
detected sodiated and potassiated phospholipids such as 
sphingomyelins (SM) and phosphatidylcholines (PC) in both 
tissues  with  distinctive  relative  abundances.  Recently,  Huang  et 
al.36 combined PSI-MS to machine learning to distinguish between 
benign and malignant breast biopsies. Different categories of lipids 
such  as  phosphatidylethanolamines  (PE),  sphingomyelins  (SM), 
and  phosphatidylcholines  (PC)  were  detected  as  sodiated  and 
potassiated ions and were employed for discrimination between the 
samples. In addition, our results are consistent with reports using 
an ambient ionization technique similar to PSI, called tissue spray 
ionization. In this technique, the tissue is cut into a small piece and 
placed  in  front  of  the  mass  spectrometer  for  direct  ionization, 
instead of placing it onto a triangular paper. Liu et al.51 applied the 
tissue  spray  technique  for  the  analysis  of  a  variety  of  organs, 
including brain, liver, kidney, adrenal gland, stomach, and spinal 
cord.  Wei  et  al.52  used  tissue  spray  for  discrimination  between 
human  lung  squamous  cell  carcinoma  and  adjacent  normal  lung 
tissues.  Kononikhin  et  al.57  reported  the  use  of  tissue  spray  for 
analysis of human brain tumors.
CONCLUSION 
Paper  spray  ionization  mass  spectrometry  (PSI-MS)  was  used 
for  discrimination  between  healthy  (negative  for  intraepithelial 
lesion or malignancy) and diseased (high-grade squamous 
intraepithelial  lesion)  blood  plasma  samples.  Minimum  sample 
preparation  was  necessary  since  lipid  ions  with  high  intensities 
were  detected  in  the  mass  spectra  after  the  application  of  few 
microliters  (10  µL)  of  blood  plasma  onto  a  triangular  paper.  In 
addition, the analyses were relatively fast, since the sample drying 
step  was  not  necessary.  Each  analysis  took  approximately  90 
seconds: ~ 30 seconds to position the triangular paper in front of 
the mass spectrometer and apply the sample and solvent onto the 
paper, and 60 seconds to acquire the data. The method was also 
quite reproducible, since huge differences in lipid intensities were 
observed only between the diseased and healthy samples. Samples 
from the same disease state showed insignificant variations in the 
intensities  of  the  predictive  ions.  Using  the  interval-successive 
projection algorithm linear discriminant analysis (iSPA-LDA), six 
ions were determined as responsible for the discrimination between 
healthy and diseased samples. The predictive ions were tentatively 
identified mostly as phospholipids, such as sphingomyelins (SM) 
and  phosphatidylcholines (PC). The current approach showed 
satisfactory accuracy (77%) and high sensitivity (86%), in addition 
to providing high values of prevalence (80% for PPV and 75% for 
NPV). Although a high-resolution mass spectrometer (Q Exactive 
hybrid Quadrupole-Orbitrap) was used to improve the 
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identification of the predictive ions, a low-resolution (LCQ Fleet 
ion trap) was used to discriminate the samples. The LCQ Fleet mass 
spectrometer is much cheaper and more common in mass 
spectrometry laboratories than the Q Exactive, especially in 
developing  countries.  The  development  of  protocols  using  low-
resolution  mass  spectrometers,  if  possible,  is  highly  desirable. 
Finally, as the diseased plasmas analyzed in this study are samples 
with  precancerous  lesions  that  can  potentially  become  cervical 
cancer over time, the combination of PSI-MS with the iSPA-LDA 
model emerges as a potential tool for early diagnosis of cervical 
cancer.  This  approach  opens  an  avenue  for  rapid  and  simple 
analysis of diseased blood plasmas that could be complementary to 
cytology or HPV test. 
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